Bridgebio Pharma Inc. (bbio 2.5 03/15/27)
13F holders, Q3 2025 (September 30)6holders +1
2new positions
1sold out
$5.53avg. 13F price*
At the end of Q3 2025, 6 institutions reported holding Bridgebio Pharma Inc. (bbio 2.5 03/15/27) in their 13F filings, up 1 from Q2 2025. 2 opened new positions and 1 sold out. The largest holders were Nomura Holdings Inc. ($15.3M), State of Wisconsin Investment Board ($4.2M) and Bank of New York Mellon Corp ($420K).
- Company
- Bridgebio Pharma Inc. (bbio 2.5 03/15/27)
- CUSIP
- 10806XAB8
- Latest filing quarter
- Q2 2026
History
Number of 13F holders
Total Exit/New Position Q2 2025 → Q3 2025
| Institutions | Total Value | |
|---|---|---|
| New Positions | 2 | $15K |
| Exits | 1 | $72.8M |
All 13F filers, Q2 2025 → Q3 2025: 1,111,000 shares bought and 58,434,433 shares sold, net −57,323,433 shares. Counts holders who added, trimmed, opened or closed a position; split-adjusted.
Ownership 6 holders
| Nomura Holdings Inc. | 0.08% | Reduce -39.6% | 294,702 | $15.3M |
| State of Wisconsin Investment Board | 0.01% | Add +50.0% | 3,000,000 | $4.2M |
| Bank of New York Mellon Corp | 0.00% | Add +50.0% | 300,000 | $420K |
| Traub Capital Management LLC | 0.01% | New | 10,000 | $14K |
| Northwestern Mutual Wealth Management Co. | 0.00% | New | 1,000 | $1K |
| Jones Financial Companies LLLP | 0.00% | No change | 1,000 | $1K |
"% of holder's portfolio" is BRIDGEBIO PHARMA INC (BBIO 2.5 03/15/27)'s weight in each manager's 13F, not the share of Bridgebio Pharma Inc. (bbio 2.5 03/15/27) the manager owns.